2）   

超大移民城市新型冠状病毒肺炎传播风险精准预测及防控策略研究（100万元），第一负责人

3）   

比尔和梅林达盖茨基金会“基于血清学和病原学检测的深圳市COVID-19患者、密切接触者和湖北返深人群健康调查（180万元），第一负责人

2）   

“深圳市新冠肺炎疫情快速监测联防联控平台”获评“中华预防医学会新冠肺炎防控大数据与人工智能最佳应用案例”（第一完成人）

2）   

Zhang Z, Bi Q, Fang S, Wei L, Wang X, He J, Wu Y, Liu X, Gao W,   Zhang R, Gong W, Su Q, Azman AS, Lessler J, Zou X. Insight into the   practical performance of RT-PCR testing for SARS-CoV-2 using serological   data: a cohort study. Lancet Microbe. 2021, Feb;2(2):e79-e87

3）   

Yang Chao,Jiang Min,Wang Xiaohui,Tang Xiujuan,Fang Shisong,Li   Hao,Zuo Le,Jiang Yixiang,Zhong Yifan,Chen Qiongcheng,Zheng Chenli,Wang Lei,Wu   Shuang,Wu Weihua,Liu Hui,Yuan Jing,Liao Xuejiao,Zhang Zhen,Shi Xiaolu,Geng   Yijie,Zhang Huan,Zheng Huanying,Wan Min,Lu Linying,Ren Xiaohu,Cui Yujun,Zou   Xuan,Feng Tiejian,Xia Junjie,Yang Ruifu,Liu Yingxia,Mei Shujiang,Li   Baisheng,Yang Zhengrong,Hu Qinghua. Viral RNA level, serum antibody   responses, and transmission risk in recovered COVID-19 patients with   recurrent positive SARS-CoV-2 RNA test results: a population-based   observational cohort study.[J]. Emerging microbes & infections,2020,9(1).

4）   

Li Yujun,Wang Haimin,Tang Xiaojuan,Fang Shisong,Ma Danting,Du   Chengzhi,Wang Yifei,Pan Hong,Yao Weitong,Zhang Renli,Zou Xuan,Zheng   Jie,Xu Liangde,Farzan Michael,Zhong Guocai. SARS-CoV-2 and three related   coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an   improved ACE2-Ig.[J]. Journal of virology,2020,94(22).

5）   

Zou Xuan,Xu ZiQian,Wang HaiRui,Wang BiXin,He   JianFan,Wang JingZhong. Correction to: Study on the COVID-19 infection   status, prevention and control strategies among people entering Shenzhen.[J].   BMC public health,2021,21(1).

6）   

Liu Yingzhi,Ling Lowell,Wong Sunny H,Wang Maggie HT,Fitzgerald   J.Ross,Zou Xuan,Fang Shisong,Liu Xiaodong,Wang Xiansong,Hu Wei,Chan   Hung,Wang Yan,Huang Dan,Li Qing,Wong Wai T,Choi Gordon,Zou Huachun,Hui David   SC,Yu Jun,Tse Gary,Gin Tony,Wu William KK,Chan Matthew TV,Zhang Lin. Outcomes   of respiratory viral-bacterial co-infection in adult hospitalized   patients[J]. EClinicalMedicine,2021,37.

7）   

Tang Xiujuan,Zhao Shi,He Daihai,Yang Lin,Wang Maggie H.,Li   Yuan,Mei Shujiang,Zou Xuan. Positive RT-PCR tests among discharged   COVID-19 patients in Shenzhen, China[J]. Infection Control & Hospital   Epidemiology,2020,41(9).

8）   

 Wang Tian,Lv Ziquan,Wen   Ying,Zou Xuan,Zhou Guohong,Cheng Jinquan,Zhong Danrong,Zhang Yanwei,Yu   Shuyuan,Liu Ning,Peng Chaoqiong,Chen Guomin,Zheng Sijia,Huang Hui,Liu   Ran,Huang Suli. Associations of plasma multiple metals with risk of   hyperuricemia: A cross-sectional study in a mid-aged and older population of   China.[J]. Chemosphere,2021,287(Pt 3).

9）   

Luo Huanle,Jia Tingting,Chen Jiamin,Zeng Shike,Qiu Zengzhao,Wu   Shu,Li Xu,Lei Yuxuan,Wang Xin,Wu Weihua,Zhang Renli,Zou Xuan,Feng   Tiejian,Ding Ruxia,Zhang Yue,Chen Yao Qing,Sun Caijun,Wang Tian,Fang   Shisong,Shu Yuelong. The Characterization of Disease Severity Associated IgG   Subclasses Response in COVID-19 Patients [J]. Frontiers in   Immunology,2021,12.

10）             

Fang Shisong,Zhang Lin,Liu Yingzhi,Xu Wenye,Wu Weihua,Huang   Ziheng,Wang Xin,Liu Hui,Sun Ying,Zhang Renli,Peng Bo,Liu Xiaodong,Sun Xiao,Yu   Jun,Chan Francis Ka Leung,Ng Siew Chien,Wong Sunny Hei,Wang Maggie Hai   Tian,Gin Tony,Joynt Gavin Matthew,Hui David Shu Cheong,Feng Tiejian,Wu   William Ka Kei,Chan Matthew Tak Vai,Zou Xuan,Xia Junjie. Lysosome   activation in peripheral blood mononuclear cells and prognostic significance   of circulating LC3B in COVID-19[J]. Briefings in Bioinformatics,2021,22(2).

11）             

Lv Qiuying,Kong Dongfeng,He Yaqing,Lu Yan,Chen Long,Zhao   Jin,Feng Siyang,Chen Yixiong,Wan Jia,Wen Ying,Gao Wei,Chen Zhigao,Tang   Xiujuan,Mei Shujiang,Zou Xuan,Feng Tiejian. A SARS-CoV-2 Delta variant   outbreak on airplane: Vaccinated air passengers are more protected than   unvaccinated.[J]. Journal of travel medicine,2021,28(8).

12）             

Cheng Cong,Wang Lei,Lyu Ziquan,Peng Bo,Li Yinghui,Kong   Dongfeng,Zuo Le,Zhang Xiaomin,Yang Chao,Liu Weiwen,Wan Jia,Tang Yijun,He   Junjia,Wen Ying,Xu Shule,Wu Weihua,Chen Ying,Liu Guangnan,Xia Junjie,Zou   Xuan,Zhang Renli,Hu Qinghua,Mei Shujiang,Feng Tiejian. Four COVID-19   Cases of New Variant B.1.351 First Emerging in South Africa in Chinese   Passengers on Same Flight - Shenzhen, China, January 2021.[J]. China CDC   weekly,2021,3(8).

13）             

He Yaqing,Niu Peihua,Peng Bo,Sun Ying,Lyu Ziquan,Zhang   Renli,Zhao Xiang,Song Yang,Feng Yenan,Tang Xiujuan,Kong Dongfeng,Wei   Xinyi,Zhu Can,Lu Qingju,Li Shimin,Xiao Xiaoliang,Liu Weiwen,He Junjia,Xia   Junjie,Chen Long,Zou Xuan,Feng Tiejian. Genome Characterization of   COVID-19 Lineage B.1.1.7 Detected in the First Six Patients of a Cluster   Outbreak - Shenzhen City, Guangdong Province, China, May 2021.[J]. China CDC   weekly,2021,3(25).

14）             

Chan Liu, Jianhua Lu, Peihua Li, Siyang Feng, Yichao Guo,   Kangguo Li, Benhua Zhao, Yanhua Su, Tianmu Chen, Xuan Zou. A   comparative study on epidemiological characteristics, transmissibility, and   pathogenicity of three COVID-19 outbreaks caused by different variants

15）             

邹旋,宋丽霞,何建凡,逯建华,王敬忠.深圳市2063例新冠肺炎密切接触者集中医学观察结果分析[J].中国公共卫生管理,2021,37(04):557-559.DOI:10.19568/j.cnki.23-1318.2021.04.0034.

16）             

 逯建华,何建凡,许舒乐,王昕,林良强,路滟,江敏,邹旋.深圳市重点传染病指数的设计与常态化应用[J].新发传染病电子杂志,2020,5(03):150-153.DOI:10.19871/j.cnki.xfcrbzz.2020.03.002.

17）             

邹旋，吴永胜，刘晓剑，黄素丽，何建凡，赵锦等. 深圳市新型冠状病毒肺炎应急响应策略和措施效果评价[J]. 中华流行病学杂志，2020,   41(08):1225-1230.

18）             

吕秋莹,梅树江,张仁利,吴永胜,何建凡,李媛,彭博,张振,逯建华,高玮,房师松,王敬忠,温莹,程聪,邹旋,夏俊杰,彭朝琼,冯铁建.新型冠状病毒肺炎精准防控体系构建与效果评价[J].新发传染病电子杂志,2020,5(04):229-233.DOI:10.19871/j.cnki.xfcrbzz.2020.04.003.